IMPPAT Phytochemical information: 
Garcinol

Garcinol
Clinical trials
Public title (as per ICTRP)Scientific title (as per ICTRP)Trial identifier
This is a single centre study wherein the safety and efficacy of combination of Pterostilbene, Garcinol,Anthocyanin will be assessed for weight management in adult male and/or female obese or overweight patients.An open label single group single centre study to evaluate the safety and efficacy of Pterostilbene, Garcinol and Anthocyanin combination for weight management in adult male and/or female obese or overweight patients.CTRI/2016/07/007089
In this study Garcinol 20% would be compared with an inert substance in reducing the risk of metabolic syndrome in obese individuals.A prospective, randomized, double-blind, placebo controlled clinical trial to evaluate the efficacy and safety of Garcinol 20% in reducing the risk of metabolic syndrome in obese individuals.CTRI/2020/02/023571